CVS Caremark to Cover Perrigo's Birth Control Pill in US At Zero Cost for Plan Sponsors CVS Caremark to Cover Perrigo's Birth Control Pill in US At Zero Cost for Plan Sponsors
CVS Caremark, the pharmacy benefit management subsidiary of CVS Health Corp, will add Perrigo ' s birth control pill to its preventive services oral contraceptives list and...Reuters Health Information (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 4, 2024 Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health Source Type: news
Amylyx Ditches Controversial ALS Drug Amylyx Ditches Controversial ALS Drug
After disappointing phase 3 trial results in ALS, Amylyx will pull Relyvrio from the market but provide it free to patients who want to stay on the medication.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 4, 2024 Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery Source Type: news
FDA Approves Zevtera (ceftobiprole medocaril sodium) for Bacteremia, Skin and Skin Structure Infections, and Pneumonia
Allschwil, Switzerland, April 04, 2024 -- Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that the... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 4, 2024 Category: Drugs & Pharmacology Source Type: news
US FDA Approves Basilea Pharmaceutica's Antibiotic US FDA Approves Basilea Pharmaceutica's Antibiotic
The U.S. health regulator approved Basilea Pharmaceutica ' s antibiotic for bacterial infections including multidrug-resistant strains, the FDA said on...Reuters Health Information (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 3, 2024 Category: Drugs & Pharmacology Tags: Infectious Diseases Source Type: news
FDA Approves New Antibiotic for Three Different Uses
The FDA approved a new antibiotic for the treatment of certain patients with Staphylococcus aureus bloodstream infections, including those with right-sided infective endocarditis; acute bacterial skin and skin structure infections; and community-acquired bacterial pneumonia. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 3, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Ceftobiprole Medocaril Sodium for Injection
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 3, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Lenz Therapeutics' Eye Drop Helps Improve Vision in Late-stage Study Lenz Therapeutics' Eye Drop Helps Improve Vision in Late-stage Study
Lenz Therapeutics said on Wednesday its lead experimental drug being tested in patients with a common age-related eye disorder showed improvement in nearsightedness in a...Reuters Health Information (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 3, 2024 Category: Drugs & Pharmacology Tags: Ophthalmology Source Type: news
Golden Lab LLC - 625783 - 03/22/2024
Unapproved New Drugs/Misbranded (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 3, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
FDA Roundup: April 2, 2024
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 2, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Drug Trials Snapshots: NGENLA
NGENLA is a human growth hormone for the treatment of children 3 years of age and older who are not growing because they have growth hormone deficiency (GHD). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 2, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer
DUBLIN, April 2, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company has completed the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 2, 2024 Category: Drugs & Pharmacology Source Type: news
How to Safely Dispose of Unused or Expired Medicine (60 seconds) - Video Transcript
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 2, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Desh ágase de manera segura de los medicamentos opioides antes de que puedan hacer daño - Transcripción
Desh ágase de manera segura de los medicamentos opioides antes de que puedan hacer daño - Transcripción (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 2, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
How to Safely Dispose of Unused or Expired Medicine - Video Transcript
How to Safely Dispose of Unused or Expired Medicine (FULL) - Video Transcript (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 2, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
How to Safely Dispose of Unused or Expired Medicine (30 seconds) - Video Transcript
How to Safely Dispose of Unused or Expired Medicine Video Transcript (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 2, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
